|Bid||44.13 x 800|
|Ask||44.18 x 900|
|Day's Range||43.65 - 45.57|
|52 Week Range||20.10 - 300.00|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||98.00|
Cowen and Co. report notes that recreational use of the drug Canada is surging, and the rise of pot is a headwind to beer sales.
Tilray CEO Says Some Cannabis Companies Misled Investors(Continued from Prior Part)Tilray CEO’s salaryLast week, Bloomberg reported a list of the highest paid CEOs in 2018. Interestingly, Tilray’s (TLRY) CEO, Brendan Kennedy, was the second
Cannabis Stocks Experienced Extended Weakness Last Week(Continued from Prior Part)Tilray fell last weekTilray (TLRY) reported its earnings on May 14. The company reported revenues of $23 million—better than the expectation of $20.2 million. The
Tilray CEO Says Some Cannabis Companies Misled InvestorsTilray’s CEO in focusLast week, Tilray’s (TLRY) CEO claimed that some cannabis companies have misled investors by inflating their capacity metrics, which could have skewed valuations
Pot stocks were more concerned with supporting inflated valuations than meeting grow expectations, according to this prominent cannabis CEO.
The "Cannabis Craze" had everyone and their brother buying up marijuana stocks. These cannabis stocks didn't have enough free-floating shares to cover the massive amount of buy interest leading them to skyrocketed at the end of 2018 far above their fair value.
Tilray: Big Price Cut after Its Q1 Earnings(Continued from Prior Part)Tilray’s valuationTilray (TLRY) stock has been trading at a premium valuation compared to its peers, which doesn’t seem justified. Tilray’s decline seemed imminent—like
Tilray: Big Price Cut after Its Q1 EarningsTilray’s rating changeTilray (TLRY) reported its first-quarter earnings on May 14. After the earnings, the stock didn’t move. Investors seemed to be disappointed with the earnings. While the company
After notching a 305% increase in net revenue over the same quarter last year, Aurora Cannabis CCO Cam Battley revealed how the company is eyeing profitability and U.S. expansion.
Tilray Back in the Negative, Reverses Positive Trend after Earnings(Continued from Prior Part)Cannabis sector mixedThe Horizons Marijuana Life Sciences ETF (HMMJ) was trading slightly lower, down 0.35% while the ETFMG Alternative Harvest ETF (MJ)
Tilray Back in the Negative, Reverses Positive Trend after EarningsTilray back in the negativeTilray (TLRY) reported its earnings yesterday with a better-than-expected top line. However, the stock reported a Q1 2019 loss per share of $0.32, which
Children’s Place, Aurora Cannabis, Tilray, Microsoft and Amazon are the companies to watch.
The Canadian marijuana grower reported a larger loss than Wall Street expected and shares were trading down Wednesday morning after rising in aftermarket trading on Tuesday.